Molecular nature and possible presence of a membranous glycan-phosphatidylinositol anchor of CA125 antigenNAGATA, A; HIROTA, N; SAKAI, T et al.Tumor biology. 1991, Vol 12, Num 5, pp 279-286, issn 1010-4283Article

Value of CA 15:3 in the follow-up of breast cancer patientsPONS-ANICET, D. M. F; KREBS, B. P; MIRA, R et al.British journal of cancer. 1987, Vol 55, Num 5, pp 567-569, issn 0007-0920Article

Predictive value of CA 125 in patients with epithelial ovarian cancer undergoing second-look laparotomyO'CONNELL, G. J; RYAN, E; MURPHY, K. J et al.Journal of tumor marker oncology. 1987, Vol 1, Num 4, pp 243-247, issn 0886-3849Article

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerCANNEY, P. A; MOORE, M; WILKINSON, P. M et al.British journal of cancer. 1984, Vol 50, Num 6, pp 765-769, issn 0007-0920Article

Intra-peritoneal CA125: a potential tumour markerREDMAN, C. W. E; LAWTON, F. G; LEWIS, P et al.Journal of tumor marker oncology. 1988, Vol 3, Num 1, pp 45-47, issn 0886-3849Article

Les nouveaux marqueurs en gynécologie oncologique = New markers in the oncological gynaecologyNAHOUL, K; SCHOLLER, R.Actualités gynécologiques (Paris. 1971). 1987, Num 18, pp 81-99, issn 0223-4661Article

An antibody-tumor model for the targeting of CA125-producing gynecologic malignanciesSAGA, T; ISHIWATA, I; KONISHI, J et al.Japanese journal of cancer research. 1990, Vol 81, Num 11, pp 1141-1148, issn 0910-5050Article

CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantationCIOBANU, N; RUNOWICZ, C. D; WIERNIK, P. H et al.American journal of obstetrics and gynecology. 1989, Vol 160, Num 2, pp 354-355, issn 0002-9378Article

CA 125 in the follow-up of patients with ovarian cancerHALILA, H; LEHTOVIRTA, P; STENMAN, U.-H et al.Acta obstetricia et gynecologica Scandinavica. 1988, Vol 67, Num 1, pp 53-58, issn 0001-6349Article

CA 125 in tissues and amniotic fluid during pregnancyQUIRK, J. G. JR; BRUNSON, G. L; LONG, C. A et al.American journal of obstetrics and gynecology. 1988, Vol 159, Num 3, pp 644-649, issn 0002-9378Conference Paper

Expression of CA 125 in adenomyosis. (With 1 color plate)KIJIMA, S; TAKAHASHI, K; KITAO, M et al.Gynecologic and obstetric investigation. 1987, Vol 23, Num 2, pp 122-123, issn 0378-7346Article

Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysisKOOMEN, G. C. M; BETJES, M. G. H; ZEMEL, D et al.Peritoneal dialysis international. 1994, Vol 14, Num 2, pp 132-136, issn 0896-8608Article

Le CA-125 en pathologie bénigne et maligne non ovarienne: étude portant sur 380 patients = CA-125 in non ovarian benign and malignant pathology: a study in 380 patientsMARECHAL, F; BERTHIOT, G; KRITLY, T et al.Bulletin du cancer. 1989, Vol 76, Num 7, pp 697-706, issn 0007-4551Article

Preoperative serum CA-125 levels in patients with surgical stage I invasive ovarian adenocarcinomaMANN, W. J; PATSNER, B; COHEN, H et al.Journal of the National Cancer Institute. 1988, Vol 80, Num 3, pp 208-209, issn 0027-8874Article

Hormonal regulation of CA125 tumor marker expression in human ovarian carcinoma cells: inhibition by glucocorticoidsKARLAN, B. Y; AMIN, W; CASPER, S. E et al.Cancer research (Baltimore). 1988, Vol 48, Num 12, pp 3502-3506, issn 0008-5472Article

Serum CA 125 measurements in the diagnosis of endometriosis recurrenceFEDELE, L; ARCAINI, L; VERCELLINI, P et al.Obstetrics and gynecology (New York. 1953). 1988, Vol 72, Num 1, pp 19-22, issn 0029-7844Article

Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinomaPATSNER, B; MANN, W. J; VISSICCHIO, M et al.Gynecologic oncology (Print). 1988, Vol 30, Num 1, pp 98-103, issn 0090-8258Article

CA 125 (cancer antigen 125): production endométriale et utilité clinique pour suivre les endométrioses = CA 125 (cancer antigen 125): endometrial production and clinical usefulness in endometriosis followingBISCHOF, P; TSENG, L; BRIOSCHI, P. A et al.Actualités gynécologiques (Paris. 1971). 1987, Num 18, pp 101-105, issn 0223-4661Article

CA-125 is not a useful marker in metastatic breast cancerSECKL, M. J; RUSTIN, G. J. S; COOMBES, R. C et al.British journal of cancer. 1992, Vol 66, Num 5, pp 875-876, issn 0007-0920Article

Serum levels of CA 125 are elevated in patients with active systemic lupus erythematosusMONCAYO, R; MONCAYO, H.Obstetrics and gynecology (New York. 1953). 1991, Vol 77, Num 6, pp 932-934, issn 0029-7844, 3 p.Article

Alpha₁-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125MOGENSEN, O; MOGENSEN, B; JAKOBSEN, A et al.Cancer. 1989, Vol 64, Num 9, pp 1867-1871, issn 0008-543X, 5 p.Article

Expression of CA125 in pancreatic carcinoma and chronic pancreatitisMACDONALD, F; DOWNING, R; ALLUM, W. H et al.British journal of cancer. 1988, Vol 58, Num 4, pp 505-506, issn 0007-0920Article

CAI25 as a serum marker for poor prognosis in ovarian malignanciesALVAREZ, R. D; TO, A; BOOTS, L. R et al.Gynecologic oncology (Print). 1987, Vol 26, Num 3, pp 284-289, issn 0090-8258Article

Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruationMASAHASHI, T; MATSUZAWA, K; OHSAWA, M et al.Obstetrics and gynecology (New York. 1953). 1988, Vol 72, Num 3, pp 328-331, issn 0029-7844, 1Article

Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cellsMATSUOKA, Y; NAKASHIMA, T; ENDO, K et al.Cancer research (Baltimore). 1987, Vol 47, Num 23, pp 6335-6340, issn 0008-5472Article